• Profile
Close

Profiling response to TNF-inhibitor treatment in axial spondyloarthritis

Arthritis Care & Research Nov 17, 2017

Alazmi M, et al. - This inquiry was set up to assess the factors associated with TNF inhibitory (TNFi) failure types and their characteristics in axial spondyloarthritis (AxSpA). Nearly 40% of the TNFi failures in AxSpA patients were attributed to primary lack of response, which was independently predicted by older age, negative HLA-B27, higher baseline disease activity and treatment with sTNFR.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay